Friday 21st June 2013 |
Text too small? |
The Financial Markets Authority is preparing to take action against two unnamed KiwiSaver issuers for making misleading statements in their offer documents as it puts the state-sponsored retirement schemes under greater scrutiny.
After reviewing 15 schemes, representing 40 percent of the market with $5 billion under management, the market watchdog contacted "a number of issuers" seeking clarity on some disclosure matters, leading to the reassessment and voluntary improvement of some offer documents, according to its June 17 report on 'monitoring of KiwiSaver offer documents'.
"FMA is currently in the process of taking action against two issuers due to non-compliance with securities legislation relating to potentially misleading statements in their offer documents," the report said. The regulator didn't name the issuers or identify what was potentially in breach.
The market watchdog is reviewing scheme disclosure to help set out the rules for issuers preparing for a new disclosure regime which seeks to standardise reporting of investment returns and fees. Under the regulations, KiwiSaver providers would have to publish one comprehensive disclosure statement every year, and four smaller, quarterly reports.
The FMA found investment returns are shown using a range of methods, and don't necessarily have internal consistency with the offer documents.
"These inconsistencies can be confusing for investors, even if there are sufficient disclosures to explain the different basis for calculation," the report said.
Risk disclosures were too generic, and needed more explanation of specific risks the funds were exposed and how those risks are managed and mitigated. Among those areas named were currency risk, benchmark risk, manager risk, derivatives and gearing risks, and life-stages products.
The watchdog was also unhappy over what it deemed a lack of disclosure about the directors and senior managers or issuers, investment managers and trustees.
BusinessDesk.co.nz
No comments yet
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report